Beatriz Alonso de Castro, Cristina Reboredo Rendo, Lourdes Calvo, Eva Perez Lopez, Silvia Antolín Novoa. "Should toxicity be taken into account in determining chemotherapy backbone in HER2-positive (HER2+) early breast cancer (eBC)?." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e12628